Zoekresultaten - Salah‐Eddin Al‐Batran

Verfijn jouw resultaten
  1. 1
    Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer

    Impact of chemotherapy on quality of life in patients with metastatic esophagogastric cancer door Salah‐Eddin Al‐Batran, Jaffer A. Ajani

    Gepubliceerd in 2010
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    mTOR as a therapeutic target in patients with gastric cancer

    mTOR as a therapeutic target in patients with gastric cancer door Salah‐Eddin Al‐Batran, Michel Ducreux, Atsushi Ohtsu

    Gepubliceerd in 2011
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine <i>versus</i> FOLFIRINOX in advanced pancreatic cancer: a systematic review

    Real-world comparative effectiveness of nab-paclitaxel plus gemcitabine <i>versus</i> FOLFIRINOX in advanced pancreatic cancer: a systematic review door E. Gabriela Chiorean, Winson Y. Cheung, Guido Giordano, George Kim, Salah‐Eddin Al‐Batran

    Gepubliceerd in 2019
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer

    The prognostic impact of epidermal growth factor receptor in patients with metastatic gastric cancer door Akin Atmaca, Dominique Werner, Claudia Pauligk, K. Steinmetz, Ralph Wirtz, Hans‐Michael Altmannsberger, Elke Jäger, Salah‐Eddin Al‐Batran

    Gepubliceerd in 2012
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  5. 5
    An Open-Label, Phase I Study of the Polo-like Kinase-1 Inhibitor, BI 2536, in Patients with Advanced Solid Tumors

    An Open-Label, Phase I Study of the Polo-like Kinase-1 Inhibitor, BI 2536, in Patients with Advanced Solid Tumors door Ralf‐Dieter Hofheinz, Salah‐Eddin Al‐Batran, Andreas Hochhaus, Elke Jäger, Volker L. Reichardt, Holger Fritsch, Dirk Trommeshauser, Gerd Munzert

    Gepubliceerd in 2010
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  6. 6
    Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Arbeitsgemeinschaft Internistische Onkologie

    Pharmacogenetic Analyses of a Phase III Trial in Metastatic Gastroesophageal Adenocarcinoma With Fluorouracil and Leucovorin Plus Either Oxaliplatin or Cisplatin: A Study of the Ar... door Eray Goekkurt, Salah‐Eddin Al‐Batran, Jörg T. Hartmann, U. Mogck, Gunter Schuch, Michael Krämer, E. Jaeger, Carsten Bokemeyer, Gerhard Ehninger, Jan Stoehlmacher

    Gepubliceerd in 2009
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  7. 7
    A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial

    A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial door Matthias Kloor, Miriam Reuschenbach, Claudia Pauligk, Julia Karbach, Mohammad‐Reza Rafiyan, Salah‐Eddin Al‐Batran, Mirjam Tariverdian, Elke Jäger, Magnus von Knebel Doeberitz

    Gepubliceerd in 2020
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  8. 8
    Phase II Trial of Biweekly Infusional Fluorouracil, Folinic Acid, and Oxaliplatin in Patients With Advanced Gastric Cancer

    Phase II Trial of Biweekly Infusional Fluorouracil, Folinic Acid, and Oxaliplatin in Patients With Advanced Gastric Cancer door Salah‐Eddin Al‐Batran, Akin Atmaca, Susanna Hegewisch‐Becker, Dirk Jaeger, S. Hahnfeld, Mathias Rummel, G. Seipelt, A. Rost, J. Orth, Alexander Knuth, E. Jaeger

    Gepubliceerd in 2004
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  9. 9
    RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomized phase III joint study of the AIO, ARO and DGAV

    RACE-trial: neoadjuvant radiochemotherapy versus chemotherapy for patients with locally advanced, potentially resectable adenocarcinoma of the gastroesophageal junction - a randomi... door Sylvie Lorenzen, Alexander Biederstädt, Ulrich Ronellenfitsch, Christoph Reißfelder, Stefan Mönig, Frederik Wenz, Claudia Pauligk, Martin Walker, Salah‐Eddin Al‐Batran, Bernhard Haller, Ralf‐Dieter Hofheinz

    Gepubliceerd in 2020
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  10. 10
    Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy

    Impact of pathologic complete response on disease-free survival in patients with esophagogastric adenocarcinoma receiving preoperative docetaxel-based chemotherapy door Sylvie Lorenzen, Peter Thuss‐Patience, Salah‐Eddin Al‐Batran, Florian Lordick, Bernhard Haller, Tibor Schuster, Claudia Pauligk, Kim Barbara Luley, Dmitry Bichev, Guido Schumacher, Nils Homann

    Gepubliceerd in 2013
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  11. 11
    Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in incidentally detected gallbladder carcinoma after simple cholecystectomy or in front of radical resection of BTC (ICC/ECC) – a phase III study of the German registry of incidental gallbladder carcinoma platform (GR)– the AIO/ CALGP/ ACO- GAIN-trial –

    Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone with or without adjuvant chemotherapy in... door Thorsten Oliver Goetze, Wolf O. Bechstein, Ulli Simone Bankstahl, Tobias Keck, Alfred Königsrainer, Sven Arke Lang, Claudia Pauligk, Pompiliu Piso, Arndt Vogel, Salah‐Eddin Al‐Batran

    Gepubliceerd in 2020
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  12. 12
    A Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Pretreated Patients with Small-Cell Lung Cancer

    A Phase II Study of the Histone Deacetylase Inhibitor Panobinostat (LBH589) in Pretreated Patients with Small-Cell Lung Cancer door Filippo de Marinis, Akin Atmaca, Marcello Tiseo, Libero Giuffreda, Antônio Rossi, Vittorio Gebbia, Chiara D’ Antonio, Laura Dal Zotto, Salah‐Eddin Al‐Batran, Silvia Marsoni, M. Wolf

    Gepubliceerd in 2013
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  13. 13
    Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis

    Prognosis of metastatic gastric and gastroesophageal junction cancer by HER2 status: a European and USA International collaborative analysis door Yelena Y. Janjigian, Dominique Werner, Claudia Pauligk, K. Steinmetz, David P. Kelsen, Elke Jäger, H. Altmannsberger, E. Robinson, Laura J. Tafe, Laura H. Tang, Manish A. Shah, Salah‐Eddin Al‐Batran

    Gepubliceerd in 2012
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  14. 14
    A phase 1/2a study to test the safety and immunogenicity of a p16<sup>INK4a</sup> peptide vaccine in patients with advanced human papillomavirus‐associated cancers

    A phase 1/2a study to test the safety and immunogenicity of a p16<sup>INK4a</sup> peptide vaccine in patients with advanced human papillomavirus‐associated cancers door Miriam Reuschenbach, Claudia Pauligk, Julia Karbach, Mohammad‐Reza Rafiyan, Matthias Kloor, Elena‐Sophie Prigge, Madeleine Sauer, Salah‐Eddin Al‐Batran, Andreas M. Kaufmann, Achim Schneider, Elke Jäger, Magnus von Knebel Doeberitz

    Gepubliceerd in 2016
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  15. 15
    Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer

    Randomised phase II trial to investigate catumaxomab (anti-EpCAM × anti-CD3) for treatment of peritoneal carcinomatosis in patients with gastric cancer door Maren Knödler, Justus Körfer, Volker Kunzmann, Jörg Trojan, S Daum, Michael Schenk, Frank Kullmann, Sebastian Schroll, Dirk Behringer, Michael Stahl, Salah‐Eddin Al‐Batran, Ulrich Hacker, Stefan Ibach, Horst Lindhofer, Florian Lordick

    Gepubliceerd in 2018
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  16. 16
    MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer

    MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer door Yelena Y. Janjigian, Eric Van Cutsem, Kei Muro, Zev A. Wainberg, Salah‐Eddin Al‐Batran, Woo Jin Hyung, Daniela Molena, Michelle Marcovitz, Dario Ruscica, Scott H. Robbins, Alejandra Negro, Josep Tabernero

    Gepubliceerd in 2022
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  17. 17
    Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive locally advanced esophagogastric adenocarcinoma: A phase <scp>II</scp> trial of the Arbeitsgemeinschaft Internistische Onkologie Gastric Cancer Study Group

    Trastuzumab in combination with 5‐fluorouracil, leucovorin, oxaliplatin and docetaxel as perioperative treatment for patients with human epidermal growth factor receptor 2‐positive... door Ralf‐Dieter Hofheinz, S. Hegewisch-Becker, Volker Kunzmann, Peter Thuss‐Patience, Martin Fuchs, Nils Homann, Ullrich Graeven, Nadine Schulte, Kirsten Merx, Michael Pohl, Swantje Held, Ralph Keller, Andrea Tannapfel, Salah‐Eddin Al‐Batran

    Gepubliceerd in 2021
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  18. 18
    Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase III “PREVENT”- (FLOT9) trial of the AIO /CAOGI /ACO

    Preventive HIPEC in combination with perioperative FLOT versus FLOT alone for resectable diffuse type gastric and gastroesophageal junction type II/III adenocarcinoma – the phase I... door Thorsten Oliver Götze, Pompiliu Piso, Sylvie Lorenzen, Ulli Simone Bankstahl, Claudia Pauligk, Moustafa Elshafei, Giuseppe Amato, Daniel Reim, Wolf O. Bechstein, Alfred Königsrainer, Stefan Mönig, Beate Rau, Matthias Schwarzbach, Salah‐Eddin Al‐Batran

    Gepubliceerd in 2021
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  19. 19
    HER2 testing in gastric cancer: results of a German expert meeting

    HER2 testing in gastric cancer: results of a German expert meeting door Florian Lordick, Salah‐Eddin Al‐Batran, Manfred Dietel, Timo Gaiser, Ralf‐Dieter Hofheinz, Thomas Kirchner, Hans Kreipe, Sylvie Lorenzen, Markus Möhler, Alexander Quaas, Christoph Röcken, Josef Rüschoff, Andrea Tannapfel, Peter Thuss‐Patience, Gustavo Baretton

    Gepubliceerd in 2017
    Volledige tekst Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  20. 20
    Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas

    Phase I clinical study of the recombinant antibody toxin scFv(FRP5)-ETA specific for the ErbB2/HER2 receptor in patients with advanced solid malignomas door Gϋnter von Minckwitz, Sebastian Harder, Sascha Hövelmann, Elke Jäger, Salah‐Eddin Al‐Batran, Sibylle Loibl, Akin Atmaca, Cimpoiasu Christian, Neumann Antje, Abera Aklil, Alexander Knuth, Manfred Kaufmann, Dirk Jäger, Alexander Maurer, Winfried S. Wels

    Gepubliceerd in 2005
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: